Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center
Oncology, Nuclear Medicine and Transplantology · 2025
DOI: 10.63946/onmt/17541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, Nuclear Medicine and Transplantology, 2025. Verfasst von Aidana Meirkhanovna Shalkarbekova und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Castleman disease (CD) is a rare lymphoproliferative disorder with heterogeneous clinical manifestations. This article presents a clinical case of HHV-8–associated multicentric Castleman disease (MCD) in an HIV-negative patient treated at the National Scientific Oncology Center. Diagnostic methods included histological and immunohistochemical evaluation, laboratory investigations, and imaging studies. The choice of therapy is discussed. The patient demonstrated resistance to rituximab monotherapy but achieved a favorable response to R-CHOP chemotherapy. This case highlights the importance of early assessment of HHV-8 status and an individualized approach to treatment selection.
Zitieren
APA
Shalkarbekova, A. M., Karabekov, A. B., Kemaykin, V. M., & Yussupova, M. M. (2025). Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center. Oncology, Nuclear Medicine and Transplantology. https://doi.org/10.63946/onmt/17541
Vancouver
Shalkarbekova AM, Karabekov AB, Kemaykin VM, Yussupova MM. Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center. Oncology, Nuclear Medicine and Transplantology. 2025. doi:10.63946/onmt/17541
BibTeX
@article{Shalkarbekova2025,
author = {Shalkarbekova, Aidana Meirkhanovna and Karabekov, Azat Baglanovich and Kemaykin, Vadim Matveevich and Yussupova, Meiramgul Muratovna},
title = {Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center},
journal = {Oncology, Nuclear Medicine and Transplantology},
year = {2025},
doi = {10.63946/onmt/17541}
}
EUVIMED